Alcide Corp preliminary experimental result obtain use formulation developed disinfection blood platelet indicate feasibility approach. The company note recent increase report transmission microbial infection recipient platelet blood transfusion patient undergo cancer therapy. The company related blood test baboon blood show significant loss vitro activity survival. The company followup study thje bacterial disinfection platelet planning evaluate inactivation virus presence platelets. The virus include Herpes Simplex Virus Type I cytomegalovirus Human Immunodeficiency Virus responsible AIDS. Reuter 